Patisiran (sodium)
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-132609-1MG | 1 mg | 621,00 | Add | |
| HY-132609-5MG | 5 mg | 1'964,00 | Add | |
| HY-132609-10MG | 10 mg | 3'250,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Patisiran sodium is a double-stranded small interfering RNA that targets a sequence within the transthyretin (TTR) messenger RNA. Patisiran sodium specifically inhibits hepatic synthesis of mutant and wild-type TTR. Patisiran sodium can be used for the research of hereditary TTR amyloidosis[1][2][3].
| Category | Oligonucleotide |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Neurological Disease, Epigenetics,Neuronal Signaling |
| Format | Solubility: H2O : 33.33 mg/mL (ultrasonic) |
| Grade | Clinical information: Launched |
| Purity | 96.72% |
| CAS-Number | 1386913-72-9 |
| Storage Conditions | -20°C (Powder, stored under nitrogen) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Blue Ice |
| Material Safety Data Sheet | Download PDF |
